3rd Quarter - Report
COMPLETE PHARMA HOLDINGS LLC (CP) (FORMERLY: MARATHON PHARMACEUTICALS, LLC) for COMPLETE PHARMA HOLDINGS LLC (CP) (FORMERLY: MARATHON PHARMACEUTICALS LLC)
Income
—
Expenses
$80,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
No specific provisions lobbied - General Support of passage for S. 3084 - American Innovation and Competitiveness Act, S. 289 - The American Cures Act and H.R. 6 - The 21st Century Cure Act Education about Marathon Pharmaceuticals future products (if approved by FDA). Education about Marathon Pharmaceuticals initiatives, role in rare diseases, precision medicine and sale of legacy products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY ARONIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.